Free Trial

Vaccine Headline Bump Didn't Last Long

US TSY FUTURES

Tsy futures back to extending late overnight lows, quickly reversing a gap bid after J&J annc 66% global effectiveness of Covid vaccine, news briefing w/US officials ongoing but follow-up headline notes slightly higher effectiveness in US of 72% and "shot's immunity likely to ramp up over time" Bbg. Yld curves back to Jan 20-25 highs.

  • 3M10Y +3.501, 101.572 (L: 97.139 / H: 101.913)
  • 2Y10Y +3.443, 95.997 (L: 91.875 / H: 96.338)
  • 2Y30Y +4.128, 172.476 (L: 167.234 / H: 172.899)
  • 5Y30Y +2.752, 140.33 (L: 136.831 / H: 140.753)
  • Current futures levels:
  • Mar 2Y up 0.25/32 at 110-15.625 (L: 110-15.25 / H: 110-15.875)
  • Mar 5Y down 1.5/32 at 125-28.25 (L: 125-28 / H: 125-31)
  • Mar 10Y down 5.5/32 at 137-2.5 (L: 137-01 / H: 137-10.5)
  • Mar 30Y down 20/32 at 168-30 (L: 168-25 / H: 169-29)
  • Mar Ultra 30Y down 1-1/32 at 205-5 (L: 204-27 / H: 207-00)

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.